Startup Approved to Let AI System Prescribe Psychiatric Medication
TL;DR
A US startup has received regulatory approval to allow an AI system to prescribe psychiatric medications, potentially without a human doctor making the final call.
Key Points
- The system guides patients through a diagnosis and prescription process via app – a workflow traditionally handled by licensed psychiatrists.
- Critics raise alarms about the risks involved with sensitive drugs like antidepressants or antipsychotics, where misdiagnosis can have severe consequences.
- The approval raises fundamental liability questions: who is responsible when the AI prescribes incorrectly?
Nauti's Take
The idea of using AI to improve psychiatric care is not inherently wrong – but granting autonomous prescribing rights is a massive leap taken well ahead of actual technical maturity. The shortage of psychiatrists is real, but it does not justify shortcuts in patient safety.
Getting antipsychotics or SSRIs via an app algorithm without meaningful human oversight leaves patients exposed. This approval smells less like medical progress and more like a regulatory gap that a startup cleverly exploited.
Sources